REFERENCES

1. Review Team, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, et al. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014; 48:467-73.
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142:1592-609.
3. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective.Semin Liver Dis. 2008; 28(4):339–50. doi: 10.1055/s-0028-1091978. [PubMed] [Cross Ref]
4. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int. 2007;6(6):572–8. [PubMed] 
5. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008; 115(5):141–50. doi: 10.1042/CS20070402. [PubMed] [Cross Ref]
6. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis.2004; 24(4):349–62. doi: 10.1055/s-2004-860864. [PubMed] [Cross Ref]
7. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221–31. doi: 10.1056/NEJMra011775. [PubMed] [Cross Ref]
8. Mavrogiannaki AN, Migdalis IN. Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. Int J Endocrinol. 2013; 2013:450639. doi: 10.1155/2013/450639.[PMC free article] [PubMed] [Cross Ref]
9. Rocha R, Cotrim HP, Carvalho FM, Siqueira AC, Braga H, Freitas LA. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet. 2005;18(5):365–70. doi: 10.1111/j.1365-277X.2005.00634.x. [PubMed] [Cross Ref]
10. Razavizade M, Jamali R, Arj A, Talari H. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int.2012; 11(5):513–20. [PubMed
11. Obesity epidemic puts millions at risk from related diseases. WHO Press Release. 1997; 46:12.
12. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology.1999; 116(6):1413–9. [PubMed]
13. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995; 22(6):1714–9. [PubMed]
14. Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian Journal of Endocrinology and Metabolism. 2013;17(4):665-671. doi:10.4103/2230-8210.113758.
15. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009; 13(1):9-19.
16. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005; 143:722–728. [PubMed]
17. Hsiao PJ, Kuo KK, Shin SJ, et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007; 22:2118–2123. [PubMed]
18. Sundaram SS, Zeitler P, Nadeau K. The Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease in Children. Current opinion in pediatrics. 2009;21(4):529-535. doi:10.1097/MOP.0b013e32832cb16f.
19. Constantine goritsas, Konstantinos spanos, Dimitrios stefanopoulos non alcoholic fatty liver disease: correlation with clinical Hormonal and biochemical parameters Hospitan Chronicles 2007, 2(3): 100-103
20. Gökmen, Fatma Yahyaoğlu, Ahbab, Süleyman, Ataoğlu, Hayriye Esra, Türker, Betül Çavuşoğlu, Çetin, Faik, Türker, Fatih, Mamaç, Rabia Yahyaoğlu, and Yenigün, Mustafa. (2016). FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics, 71(4), 221-225.